ANO1 and breast carcinoma: In some subtypes of cancers, such as human-papilloma-virus-positive head and neck squamous cell carcinoma, pancreatic neuro-endocrine tumors, and estrogen-receptor-positive and human epidermal growth factor receptor 2-positive breast cancers, there is no over-expression of TMEM16A [71].